ArticleMedicine2026
Association between hepatic steatosis index and gallstones in US adults: A cross-sectional study of NHANES 2017-2020.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The hepatic steatosis index (HSI) is a practical indicator for screening fatty liver disease. This research aimed to evaluate the relationship between HSI and gallstones. This cross-sectional population-based investigation utilized data from the National Health and Nutrition Examination Survey (NHANES) spanning 2017 to 2020. Gallstones were defined as a self-reported history of physician-diagnosed gallstones. We systematically examined the relationship between HSI and gallstones using multivariable logistic regression models that accounted for survey weighting, with stratified analyses conducted to test the consistency of the link across diverse demographic groups. This study comprised 6368 participants above 20 years old, 680 of whom had gallstones. A positive association was observed between HSI and gallstones. Following comprehensive adjustment for potential confounding variables, each unit increase in HSI was linked to a 5% rise in prevalence of gallstones (odds ratio = 1.05, 95% confidence interval = 1.04-1.07). Categorizing HSIs into quartiles, it was observed that participants in the top HSI quartile exhibited a significantly higher prevalence of gallstones relative to those in the bottom quartile (odds ratio = 3.78, 95% confidence interval = 2.60-5.50). Stratified analyses further confirmed that this association stayed statistically significant across most subgroups. In this cross-sectional study, higher HSI levels were associated with a higher prevalence of gallstones. However, longitudinal studies are needed to confirm these findings and clarify the underlying mechanisms.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.